579 related articles for article (PubMed ID: 23481201)
1. Cadherins and epithelial-to-mesenchymal transition.
Gheldof A; Berx G
Prog Mol Biol Transl Sci; 2013; 116():317-36. PubMed ID: 23481201
[TBL] [Abstract][Full Text] [Related]
2. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
Nam EH; Lee Y; Park YK; Lee JW; Kim S
Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
[TBL] [Abstract][Full Text] [Related]
3. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
4. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling.
Derycke LD; Bracke ME
Int J Dev Biol; 2004; 48(5-6):463-76. PubMed ID: 15349821
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
Murali AK; Norris JS
J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of cadherins during development and carcinogenesis.
Peinado H; Portillo F; Cano A
Int J Dev Biol; 2004; 48(5-6):365-75. PubMed ID: 15349812
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
8. Cadherin dynamics during neural crest cell ontogeny.
Taneyhill LA; Schiffmacher AT
Prog Mol Biol Transl Sci; 2013; 116():291-315. PubMed ID: 23481200
[TBL] [Abstract][Full Text] [Related]
9. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
10. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.
Nakajima S; Doi R; Toyoda E; Tsuji S; Wada M; Koizumi M; Tulachan SS; Ito D; Kami K; Mori T; Kawaguchi Y; Fujimoto K; Hosotani R; Imamura M
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4125-33. PubMed ID: 15217949
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas.
Wallesch M; Pachow D; Blücher C; Firsching R; Warnke JP; Braunsdorf WEK; Kirches E; Mawrin C
J Neurol Sci; 2017 Sep; 380():112-121. PubMed ID: 28870549
[TBL] [Abstract][Full Text] [Related]
12. Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis.
Todosi AM; Gavrilescu MM; Aniţei GM; Filip B; Scripcariu V
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1106-11. PubMed ID: 23700897
[TBL] [Abstract][Full Text] [Related]
13. Cadherins in the human placenta--epithelial-mesenchymal transition (EMT) and placental development.
Kokkinos MI; Murthi P; Wafai R; Thompson EW; Newgreen DF
Placenta; 2010 Sep; 31(9):747-55. PubMed ID: 20659767
[TBL] [Abstract][Full Text] [Related]
14. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
[TBL] [Abstract][Full Text] [Related]
15. Cadherin profiling for therapeutic interventions in Epithelial Mesenchymal Transition (EMT) and tumorigenesis.
Pal M; Bhattacharya S; Kalyan G; Hazra S
Exp Cell Res; 2018 Jul; 368(2):137-146. PubMed ID: 29674112
[TBL] [Abstract][Full Text] [Related]
16. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition in gastric cancer (Review).
Katoh M
Int J Oncol; 2005 Dec; 27(6):1677-83. PubMed ID: 16273224
[TBL] [Abstract][Full Text] [Related]
18. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
19. Type I collagen down-regulates E-cadherin expression by increasing PI3KCA in cancer cells.
Cheng JC; Leung PC
Cancer Lett; 2011 May; 304(2):107-16. PubMed ID: 21377268
[TBL] [Abstract][Full Text] [Related]
20. Resolving time and space constraints during neural crest formation and delamination.
Duband JL; Dady A; Fleury V
Curr Top Dev Biol; 2015; 111():27-67. PubMed ID: 25662257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]